Agilus Diagnostics has installed the Illumina NovaSeq X platform, marking a significant upgrade to its digital and technology infrastructure as the company strengthens its precision genomics capabilities across India’s healthcare sector.
The addition of the high-throughput sequencing platform is expected to anchor Agilus’ precision genomics function, enabling large-scale sequencing programs, strengthening multi-omic analysis capabilities, and supporting scalable, secure, and future-ready operations aligned with the company’s business objectives. The initiative is being led under the leadership of MD and CEO Dr Anand K.
According to the company, the rollout reflects its broader strategy of using advanced technology to drive operational excellence, efficiency, and innovation. The NovaSeq X platform is set to play a central role in advancing personalised medicine initiatives, enhancing digital resilience, and providing robust technology support to cross-functional teams across the enterprise.
